Furen Pharamaceutical Group Co.,Ltd established in 1998, it is a comprehensive group corporation that specializes in pharmceutical and commits itself to R&D, production, operation, investment and management. Following the business philosophy of "Heal the World with Medicine, Benefit People with Bendvolence", Furen sets "Special, Professional, Dedicated" as the guideline for development. Since 2001, Furen has accomplished 5 mergers and acquisitions successively in 6 years, and formed an industrial system through delicate restructuring.
The system of the group owns several wholly--owned or holding subsidiaries, including Henan Frentang Pharmaceutical Co., Ltd,. Henan Furen Huaiqingtang Pharmaceutical Co.,Ltd., Kaifeng Pharmaceutical (Group) Co., Ltd., Kaifeng Yugang Pharmaceutical Co., Ltd., Henan Tongyuan Pharmaceutical Co., Ltd., Furen Pharmaceutical R&D Co., Ltd., Furen Hetero Onco Therapeutics Ltd., and Furen Medicines Group Commercial Co., Ltd. Its product lines cover Chinese and western pharmaceutical preparations, bilchemical and biological pharmaceutical ingredients, etc. After the PIO of the Henan Furentang in 2005 in the Shanghai Stock Exchange, the power of captical not only pushed Furen on to a fast track, but also exalted its position in the industry. In 2014, the National Ministry of Industry and Information Technology published an "Annals of Chinese Medical Statistics" in which Furen ranked 25th on the general pharmaceutical enterprise column by prime operating revenue.
"Putting variety as the Core and M&A as the mainline"-the development strategy of Furen at the early stage has stimulated a rapid growth of productivity and product line in a rather short time. To date, Furen has already owned 23 dosage forms and near 1,500 varieties, ranking among the top in China on general production capacity for preparations, including liquid injections, lyophilized powder for injections, and oral sodium preparation. A total of 187 products of Furen (dosage form,strength) were named on the National Essential Drugs List 2012, making Furen one of the enterprises ranking atop in the number of listed products in China. In the Catalogue of Drugs for Basic National Insurance published in 2009, 413 of its products were listed including 255 of Class-A varieties and 158 of Class-B varieties, making it one of the enterprises ranking atop in the number of products on the list in China."Furen" has been identified as a pretigious trademark of China.
"Making high-quality medicines for common people" has long been adopted as the corporate mission of Furen. In respone to the new market environment, Furen has camp up with a guiding principle of "Blockbuster-led, Profit-oriented and Structrue-supported" operation, and has put into practice of a marketing principle of " Focusing on Variety, Making Breakthrough on Single Aspect". As a "Professional Manufacturer of Antiviral Drugs" with a prestigious reputation in its specialty, Furen is commited to safeguared Chinese people′s life quality and health with its 39 antiviral products and has always complied with the guideline of "Quantity and Cost Give Way to Quality" and upheld the value of "Harmony without uniformity, winning for all".As a inclusive enterprise, Furen will always play by the rules.
